36th week of 2019 patent applcation highlights part 6 |
Patent application number | Title | Published |
20190269562 | Anti-Microbial Balanced Weave and Process Therefore - In an embodiment, a material includes at least one outer section and a midsection attached to the outer section. The midsection includes a first antimicrobial membrane patch layer configured to contact a body, a second antimicrobial membrane patch layer disposed adjacent to the first antimicrobial patch layer, and an air gap disposed between the first patch and second antimicrobial patch layers. The first and second antimicrobial patch layers each are formed from respective balanced warp tows and fill tows in a plain-weave pattern, and each layer include copper filaments disposed in a plurality of the tows, each of the copper filaments including at least Cu+ or Cu+++ ions. Such a material may be suitable for notification and protection of a body from a soil deposited on the material. | 2019-09-05 |
20190269563 | Disposable Wearing Article and Method of Bonding Perforated Nonwoven Fabric - To certainly fix the peripheral portion of a hole to a support sheet without losing flexibility. The above problem is solved by providing a cover nonwoven fabric in which a plurality of holes penetrating front and back surfaces at intervals, and a liquid impervious sheet in which the cover nonwoven fabric is bonded via a hot melt adhesive, in the cover nonwoven fabric, the peripheral portions of the holes are warped portion warped toward the liquid impervious sheet side, at least a tip portion of the warped portion of the cover nonwoven fabric has an adhesive portion bonded to the liquid impervious sheet via the hot melt adhesive, and a portion of the cover nonwoven fabric other than the adhesive portion is not adhered to the liquid impervious sheet. | 2019-09-05 |
20190269564 | ABSORBENT ARTICLE WITH A FOAM AND FIBER COMPOSITE - The foam and fiber composite can provide an absorbent article with improved dryness and an improved liquid distribution capability. The foam and fiber composite can be formed from at least two materials. The first material is an open cell foam material and the second material is a fibrous material. A plurality of the fibers forming the fibrous material can be fluid inserted into the open cell foam material thereby forming the foam and fiber composite. In various embodiments, the foam and fiber composite can be incorporated into an absorbent article as a component of an absorbent system located between a topsheet layer and a backsheet layer of the absorbent article. | 2019-09-05 |
20190269565 | METHODS AND APPARATUS FOR APPLICATION OF NESTED ZERO WASTE EAR TO TRAVELING WEB - A method of forming a disposable product includes feeding an incoming web of ear material, engaging the web with a rotating anvil, cutting ears from the web via the rotating anvil and interaction thereof with a corresponding die, so as to form pairs of ears having complimentary and nested ear shapes, and coupling the ears to at least one of a wing and a web of chassis material. In feeding the incoming web of ear material, the speed of the web is selectively varied between at least a first speed and a second speed, with the web being fed to the rotating die and anvil at the first speed to result in the cut ear shapes having a first height and the web being fed to the rotating die and anvil at the second speed to result in the cut ear shapes having a second height. | 2019-09-05 |
20190269566 | MOVING DEVICE - A moving device adapted to be actuated by a prime mover is disclosed. The moving device allows a caregiver to ride thereon. The moving device comprises a vehicle body and a plurality of rotors. The vehicle body includes a first frame portion and a second frame portion. The first frame portion allows the caregiver to ride thereon and the second frame portion allows a care receiver to ride thereon. The plurality of rotors are provided on the first frame portion and are rotatable in accordance with movement of the vehicle body. A wheel base defined by the plurality of rotors is constant. The second frame portion is provided on the first frame portion so as to be movable in accordance with a motion of the caregiver riding on and getting off the first frame portion. | 2019-09-05 |
20190269567 | DRIVING DEVICE CAPABLE OF WALKING AND STAIR-CLIMBING BY ELECTRIC POWER - The present invention discloses a driving device capable of walking and stair-climbing by electric power which adopts a combination of a walking mechanism and a climbing carrier to create inventive planetary gear transmission principles. When walking on a flat ground, a driving part drives a sun gear to rotate in a positive direction, two walking wheels are in contact with the ground at the same time, the sun gear drives a planet gear to rotate in a negative direction around a planet shaft, and inner teeth and outer teeth of a gear ring rotate in the negative direction synchronously with the planet gear, thereby a transmission gear drives the walking wheel to rotate in the positive direction to realize rotation of walking. When climbing stairs, the sun gear rotates in the positive direction, the walking wheel is obstructed by stair, the transmission gear, the inner and outer teeth of the gear ring stop rotating, and the sun gear drives the planet gear to revolute along the inner teeth in the positive direction, thereby the planet shaft drives the climbing carrier to rotate in the positive direction to realize climbing cross obstacles. Thus, the present invention solves the problem of the known planetary wheel structure that the climbing carrier is driven to rotate in opposite direction when the walking wheel cannot rotate such and thus is difficult to realize the function of stair-climbing, and has advantages of simple structure and safe and reliable use. | 2019-09-05 |
20190269568 | AIR MATTRESS FOR GATCH BED - An air mattress for a bed, placed on a plurality of bottoms including a back bottom and used for the bed that performs a back raising operation for raising the back bottom, including air cells extending to a first direction and being arranged in parallel in a second direction; a first unit capable of inflating and deflating each of the air cells; and, a controller configured to control to alternately inflate and deflate the air cells by successively increasing and decreasing a pressure of air to be supplied to each of the air cells. The first unit inflate and deflate the air cells by n lines independent from each other, where n is equal to or greater than 3, and the controller controls inflation and deflation of air cells of one line during at least a part of a period in which a back bottom is being raised. | 2019-09-05 |
20190269569 | PATIENT SUPPORT SURFACE MODULE WITH LOCKING DEVICE - A patient support surface module for supporting a patient body parthas a locking device with a plug bolt for engaging a receiving opening in a patient table or the like. A bolt element is movably accommodated in a through opening in the plug bolt, and a longitudinal axis of the through opening extends at an acute angle relative to a longitudinal axis of the plug bolt. The bolt element can engage a receiving opening for securing the plug bolt in the receiving opening. An actuating element is operably connected to the bolt element for moving the bolt element and the locking device between locked and released positions. | 2019-09-05 |
20190269570 | MASSAGE SYSTEM AND METHOD OF CONTROLLING AT LEAST ONE MASSAGE ACTUATOR - A massage system for a bed having a mattress comprises a massage controller adapted to control at least one massage actuator acting on the mattress. The massage controller is adapted, in a calibration mode of operation, to drive the at least one massage actuator with a test signal for excitation of the mattress, to receive measured values which represent a response of the mattress to the excitation with the test signal, and to determine, on the basis of the measured values and the test signal, a response characteristic represented by an oscillation response of the massage actuator and the mattress. In addition, the massage controller is adapted to control, in a massage mode of operation, the at least one massage actuator based on an adjustable massage parameter and the oscillation response. | 2019-09-05 |
20190269571 | DAMPING-ADJUSTABLE SHOULDER JOINT TRACKING APPARATUS FOR VARIOUS UPPER EXTREMITY REHABILITATION MODES - A shoulder joint tracking apparatus includes a gravity compensation spring that compensates for a vertical movement of a shoulder joint of a trainee, a weight of an arm, and gravity to a weight of a rehabilitation exercise device attached to the arm, and a shoulder joint tracking device that is provided at one side of the shoulder rehabilitation apparatus, is connected to the gravity compensation spring, and applies a damping force corresponding to a force applied by the trainee, in a direction opposite to a direction in which the force is applied, to control a vertical movement of the shoulder rehabilitation apparatus. | 2019-09-05 |
20190269572 | MOBILE ASSISTANCE ROBOT COMPRISING AT LEAST ONE PIVOTING BEARING SYSTEM - Disclosed is a mobile robot which includes: a mobile base which exhibits a control system configured to control the characteristics of the motion of the mobile base; and a bearing system configured to be grasped by a person. The bearing system is configured to pivot freely with respect to the mobile base about a vertical rotation axis. The robot includes at least one first sensor configured to detect at least one characteristic of a rotation motion of the bearing system with respect to the mobile base and to advise the control system which is configured to modify the trajectory of the robot as a function of the characteristic, detected by the first sensor, of the rotation motion of the bearing system. | 2019-09-05 |
20190269573 | PHYSICAL THERAPY DEVICE - The physical therapy device is a therapeutic device. The physical therapy device is adapted for use with a patient. The physical therapy device massages a leg of the patient. The physical therapy device comprises a base, a plurality of telescopic stanchions, and a massaging structure. The massaging structure and the base attach to the plurality of telescopic stanchions. The plurality of telescopic structures elevate the massaging structure above a supporting surface. The massaging structure rotates such that the rotation of the massaging structure massages the leg of the patient. The base is a pedestal that forms the final link in the load path between the massaging structure and a supporting surface. | 2019-09-05 |
20190269574 | SYSTEMS AND METHODS FOR IMPROVED POST-RESUSCITATION RECOVERY - A method for performing cardiopulmonary resuscitation (CPR) includes elevating the head, heart and shoulders of an individual from a starting elevation angle to a final elevation angle greater than zero degrees relative to horizontal while performing CPR by repeatedly compressing the chest. The method includes elevating the brain within a time period selected to be slow enough to permit a sufficient amount of blood to flow to the brain throughout the elevation time period. The method also includes regulating the intrathoracic pressure of the individual while performing CPR. The performance of chest compressions is stopped and after stopping the performance of chest compressions, the head, heart, and shoulders are promptly from the final elevation angle within a timeframe selected to prevent significant drainage of blood from the brain until the head, heart and shoulders are lowered. | 2019-09-05 |
20190269575 | PRESERVATIVE REMOVAL FROM EYE DROPS CONTAINING HYDROPHILIC DRUGS - A particulate plug for removing a preservative from a solution, suspension, or emulsion comprising a drug is presented. The plug comprises microparticles of a homopolymer comprising a hydrophilic repeating unit or of a copolymer comprising at least one hydrophilic repeating unit and at least one hydrophobic repeating unit. The microparticles are irregular-shaped rigid aggregates and are sized and packed to yield a hydraulic permeability greater than 0.01 Da. The homopolymers have absorbed portions of a preservative to be removed and/or a drug for delivery in solution, as can the copolymer. | 2019-09-05 |
20190269576 | SYSTEMS AND METHODS FOR IDENTIFYING MEDICINES DEPOSITED IN A COMPARTMENT OF A PILL BOX ACCORDING TO A PRESCRIPTION - The disclosure relates to a system for identifying medicines, comprising a first measurement device for identifying, from the top, at least one first medicine deposited in a compartment of a pill box and analysing at least one identifying characteristic of the first medicine; and a second measurement device for identifying, from the bottom, at least one second medicine deposited in the compartment of said pill box and analysing at least one identifying characteristic of the second medicine. The system comprises a device for comparing the characteristic of the first medicine and the characteristic of the second medicine, for determining at least one validated medicine and comparing the characteristic of the validated medicine with medicine signature characteristics. The system also comprises a validation device for obtaining an identified content for the compartment and comparing the identified content with a prescription. Methods for identifying and validating medicines are also disclosed. | 2019-09-05 |
20190269577 | BOTTLE ASSEMBLY - A bottle assembly includes a container having an open end, a closed end, a base portion, and a neck together defining a liquid chamber within the container. The neck has a rim defining the open end of the container. The bottle assembly also includes a collar assembly generally defining a closure for the container. The collar assembly is configured for releasable engagement with the neck of the container over the open end thereof. The collar assembly includes a collar and a nipple. The bottle assembly further includes a cap including a closed end, an open end, and a side wall extending between the closed end and the open end together defining an interior. The cap is configured for releasable engagement with the collar assembly such that the nipple is received within the interior of the cap. In some embodiments, the bottle assembly includes a vent assembly positionable at least in part on the rim of the container to permit venting of the container during use. | 2019-09-05 |
20190269578 | BABY BOTTLE APPARATUS - An improved baby bottle apparatus having a baby bottle adapted to be filled with a liquid and any chosen additives and then releasably attached to a base member with the base member adapted to releasably connect with the bottle member and heat a liquid to a desired temperature and stir the liquid to mix any chosen additives added to the liquid before a baby sucks on the nipple and drinks the liquid. | 2019-09-05 |
20190269579 | Dental Varnish - Provided is a dental varnish composition comprising: a) a resin composition comprising: (i) an adhesive resin prepared from: one or more acidic monomers selected from 4-META, PMGDM, HEMA-phosphate, NTG-GMA, or salts thereof; and MDP; ii) a base resin prepared from: a high molecular weight monomer selected from Bis-GMA, UDMA, Bis-EMA or combinations thereof; and a low molecular weight monomer selected from TEGDMA, MMA, PEGDMA or combinations thereof; iii) a solvent; iv) a photoinitiator; v) HEMA or salts thereof; c) pigment; and d) optionally a filler. | 2019-09-05 |
20190269580 | RESIN COMPOSITE AND RESTORATION CONTAINING AZOLE-FUNCTIONALIZED SILICA - A resin composite containing azole-functionalized silica nanoparticles. The resin composite further includes a polymerizable monomer and a polymerization initiator system. A dental restoration fabricated by curing the resin composite is also specified. | 2019-09-05 |
20190269581 | A SOLID COSMETIC COMPOSITION COMPRISING A FATTY ACID-BASED GELLING AGENT AND A CO-GELLING AGENT - A solid state, oil gel composition for keratinous substance, such as skin, contains (a) at least one fatty acid-based gelling agent; (b) at least one polysaccharide fatty acid ester; and (c) at least one oil. An embodiment according to the present invention provides improved storage stability, morphological stability, and application property. | 2019-09-05 |
20190269582 | METHOD FOR PREPARING HYALURONIC ACID DERMAL FILLERS, DERMAL FILLERS OBTAINED THEREBY AND THEIR USE - The present invention generally relates to the field of hyaluronic acid (HA) dermal fillers, and more specifically to methods for preparing crosslinked HA-based compositions in the form of a gel comprising high-temperature dialysis and/or crosslinking in the presence of phosphate and an alkaline metal halide salt. The present invention further relates to crosslinked HA-based gel compositions prepared by said methods and their use as dermal fillers in aesthetic applications such as wrinkle treatments. | 2019-09-05 |
20190269583 | WATER-IN-OIL TYPE EMULSION COSMETIC - The present invention provides a water-in-oil type emulsion cosmetic which has a fresh and smooth feeling to the touch; forms a uniform coating film once applied; can make skin unevenness such as pores look less prominent while covering discolorations such as age spots and freckles; and does not give an impression of thick application. The water-in-oil emulsion cosmetic is characterized by including (A) 0.1-10% by mass of a pigment-grade titanium dioxide and (B) 0.01-2% by mass of sodium acrylate grafted starch. It is preferred that this cosmetic further includes (C) spherical particles and/or (D) a silicone elastomer. | 2019-09-05 |
20190269584 | STABILISED MULTIPLE EMULSIONS AS SKIN PROTECTION PRODUCT - The invention relates to stabilised multiple emulsions comprising the compounds a), b) and c), methods for the stabilisation of multiple emulsions and the use of multiple emulsions as skin protection products, in particular for protection against aqueous noxa, where: a) at least one aliphatic unbranched diol with 2 to 4 carbon atoms in the hydrocarbon chain, b) at least one further branched or unbranched aliphatic diol with 4 to 12 carbon atoms in the hydrocarbon chain that is different from a), whereby the hydrocarbon chain may be interrupted by an oxygen atom, c) at least one single-value aliphatic alcohol with 12 to 30 carbon atoms in the hydrocarbon chain. | 2019-09-05 |
20190269585 | THICKENING AND ELONGATION OF KERATINOUS FIBERS - Inventive embodiments include a formulation, that includes at least one pigment encapsulated by a transparent, unbreakable and non-absorbing material; at least one elongating agent; at least two adhesive agents; at least one continuous phase viscosity modifying agent; and at least one or more waxes selected from a group that includes naturally derived and synthetic waxes, hard and soft, in a concentration 10-20% weight. | 2019-09-05 |
20190269586 | Dentifrice Composition Comprising Zinc Oxide and Zinc Citrate - Described herein are oral care compositions comprising a combination of zinc oxide and zinc citrate, and methods of preparing and using the same. | 2019-09-05 |
20190269587 | Natural Hydrocarbon/Ester Compositions with Improved Sensory Properties, Formulations and Related Methods - Described herein is an invention that includes a spreadable conditioning composition comprising a blend of: a branched hydrocarbon and an ester having a kinematic viscosity of less than or equal to about 100 centistokes. The composition may be natural, for example, if each of the branched hydrocarbon and the ester are independently vegetable-derived. In addition, the composition may lack ingredients that are derived from a palm oil. In an embodiment, the composition is a blend of hydrogenated farnesene and an esters selected from glyceryl triheptanoate, dicapryl succinate, heptyl undecylenate, and mixtures thereof. The composition exhibits an average spreading velocity of about 4 to about 8. Also disclosed are formulations for use in products of personal care, home/institutional care, industry, pharmaceutical and medical and veterinary care and related methods. | 2019-09-05 |
20190269588 | Fluoride Free and Anionic Surfactant Free Dentifrice Having a High Micro Efficacy - An oral care composition and method are described in which the composition is free of an anionic surfactant and a fluoride source. | 2019-09-05 |
20190269589 | ALCOHOL-BASED HAND CONDITIONERS FOR REPEATED USE - Alcohol-based hand conditioners are provided. The alcohol-based hand conditioners have superior aesthetics suitable for use in rapid workflow environments. They are non-greasy and low residue, and thus do not leave a sticky or tacky feeling on the hands following application. | 2019-09-05 |
20190269590 | REDUCING COLOUR LOSS FROM A DYED MATERIAL BY USING AN AMINE SALT OF A CARBOXYLIC ACID - A method of combatting colour loss from a dyed material, the method comprising contacting the material with a composition comprising an amine salt of a carboxylic acid wherein the carboxylic acid has 4 to 10 carbon atoms. | 2019-09-05 |
20190269591 | METHOD OF TREATING A MATERIAL WITH AN AMINE SALT OF A CARBOXYLIC ACID - A method of treating a material, the method comprising contacting the material with a composition comprising an amine salt of a carboxylic acid wherein the carboxylic acid has 4 to 10 carbon atoms. | 2019-09-05 |
20190269592 | Clear or Translucent Composition - The present disclosure relates to a clear or translucent composition which takes the form of a solid, a semi-solid or a viscous gel. The inventive composition contains a mixture of at least two amino acid-based gelatinizing agents, at least one polyamide resin, a non ionic, unsaturated fatty alcohol in an amount which reduces the dissolution temperature of the gelatinizing agents to allow processing at or below 115° C., an alkyl dimethicone, and an oil and/or a polymer component. Additional ingredients depending on the application may also be included in the clear or translucent composition. The present disclosure also relates to methods of producing the clear or translucent composition of the disclosure and uses thereof. | 2019-09-05 |
20190269593 | COMPOSITION FOR PROMOTING HAIR GROWTH CONTAINING NOVEL PANTETHEINE DERIVATIVE - Provided is a composition for promoting hair growth, containing, as an active ingredient, a new compound represented by the following formula 1 or a salt thereof, which exhibits an excellent effect of promoting the growth of dermal papilla cells to thereby exhibit the effect of promoting hair growth: | 2019-09-05 |
20190269594 | COSMETIC COMPOSITION COMPRISING NATURAL ACTIVES - Disclosed is a cosmetic composition comprising: (i) 0.1 to 10 % by weight pongamol; (ii) 0.1 to 10 % by weight karanjin; and, (iii) 0.1 to 40% by weight of a solvent whose Total Hildebrand Parameter (δt) value is 18 to 26 MPa | 2019-09-05 |
20190269595 | TOPICAL COSMETIC TREATMENT OF SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS - The invention provides a method for the topical non therapeutical cosmetic treatment of the scalp comprising applying to the scalp an effective amount of at least one alkyl-phthalide or a plant extract comprising mainly said alkyl-phthalide. In particular, the treatment is an anti-dandruff treatment. According to the invention, a CO | 2019-09-05 |
20190269596 | COSMETIC USE AND METHOD FOR IMPROVING PHYSIOLOGICAL FUNCTIONS OF THE SKIN BY INCREASING THE EXPRESSION OF UBIAD1 - The present invention relates to a cosmetic use of a composition comprising a peptide of formula (I) or its derivative for improving physiological functions of the skin comprising the step of contacting skin, skin appendages or epidermal cells including keratinocytes with said composition and increasing the expression of Ubiad1 in such skin, skin appendages or epidermal cells. The invention also relates to a method of increasing the expression of Ubiad1 in skin, skin appendages or epidermal cells including keratinocytes, comprising contacting such skin, skin appendages or epidermal cells with a composition containing the peptide of formula (I) or the derivative thereof. The increased expression of Ubiad1 in the skin, skin appendages or epidermal cells will help for the improvement of the physiological functions of the skin. | 2019-09-05 |
20190269597 | HYALURONIC ACID DERMAL FILLERS CROSSLINKED WITH CITRIC ACID, METHOD FOR MAKING SAME AND USES THEREOF - The present invention generally relates to hyaluronic acid-based compositions for aesthetic use, and more specifically to a dermal filler composition comprising hyaluronic acid crosslinked with citric acid or a salt thereof. Furthermore, the present invention relates to a method for preparing said dermal filler composition and its use for aesthetic purposes, in particular for skin rejuvenation and correction of fine lines. | 2019-09-05 |
20190269598 | OIL-IN-WATER TYPE DERMATOLOGICAL COMPOSITION FOR EXTERNAL USE - An oil-in-water emulsion composition for skin includes 0.2 to 2.5% by mass of polyisobutene having a relative mass in a range of 30,000 to 100,000. The composition is applied to skin except for a lip. | 2019-09-05 |
20190269599 | SILICON-CONTAINING POLYOLEFINS IN PERSONAL CARE APPLICATIONS - The present invention provides personal care formulations containing silane functionalized polyolefins and having improved sensory feel, as well as being non-tacky and easily spreadable on skin. The present invention also provides a method for treating the body by applying the aforesaid personal care formulations externally to the body. The present invention also provides a method for improving the sensory feel of personal care formulations by including silane functionalized polyolefins in the formulations. | 2019-09-05 |
20190269600 | Disposable Toothbrush Having Toothpaste Composition Bonded to Bristles Thereof - A disposable toothbrush having a toothpaste composition distributed over the bristles of the toothbrush without the use of metal graft initiators and catalysts, and in which the toothpaste and the flavoring is maintained for an extended period of time. | 2019-09-05 |
20190269601 | Oral Care Compositions with Increased Whitening Efficacy - An oral care composition and method for whitening teeth is disclosed. The oral care composition includes an orally acceptable vehicle, a blue dye and/or blue pigment having a blue to blue-violet color with a hue angle in the CIELAB system from about 200 to about 320 degrees, and a phosphate/acrylate copolymer. | 2019-09-05 |
20190269602 | METHODS FOR STYLING HAIR FIBERS - A method for styling hair fibers, a kit and uses are provided. A method for styling hair fibers, preferably human hair fibers, comprises the following steps: providing a hair styling composition comprising, in a cosmetically acceptable carrier, a film-forming polymer; applying the hair styling composition to the hair fibers; heating the hair fibers comprising the hair styling composition at a temperature from 80 C to 230 C; setting the hair fibers in a hair style without subsequent rinsing; and cooling to room temperature. | 2019-09-05 |
20190269603 | PROCESS FOR THE PREPARATION OF MICROCAPSULES - The present invention relates to a new process for the preparation of microcapsules. Microcapsules obtainable by said process are also an object of the invention. Perfuming compositions and consumer products comprising said capsules, in particular perfumed consumer products in the form of home care or personal care products, are also part of the invention. | 2019-09-05 |
20190269604 | COSMETIC COMPOSITION WITH SELF-FOAMING FUNCTION - The present invention relates to a cosmetic composition containing volatile oil for skin care. The cosmetic composition contains volatile oil instead of a fluorine compound, and thus provides a cleansing effect, such as removing sebum and waste substances, and a skin care effect, such as sebum improvement or skin texture improvement, through bubbles by a self-foaming function. Furthermore, the cosmetic composition does not a fluorine compound, which is difficult to manage as a raw material for cosmetic products in the prior art, and thus is expected to further reduce environmental harmfulness. | 2019-09-05 |
20190269605 | SKIN CARE COMPOSITION - An external composition for skin comprises 0.1% by mass to 8% by mass of a non-emulsified silicone elastomer; a polyether-modified silicone surfactant; and a hydrophilic nonionic surfactant. The hydrophilic nonionic surfactant comprises a glycerin-derived surfactant. The polyether-modified silicone surfactant is 0.3 part by mass or more with respect to 1 part by mass of the silicone elastomer. The glycerin-derived surfactant is 0.2 part by mass or more with respect to 1 part by mass of the silicone elastomer. In a case where an amphoteric surfactant is included, the amphoteric surfactant is 1.5 parts by mass or less with respect to 1 part by mass of the glycerin-derived surfactant. The viscosity of the composition is 9,500 mPa·s or less. | 2019-09-05 |
20190269606 | TOOTHPASTE COMPOSITION AND METHOD OF MAKING SAME - A toothpaste composition having a plant oil constituent together with white or a close shade of white coconut shell activated charcoal constituent is disclosed herein. | 2019-09-05 |
20190269607 | ORAL HEALTH COMPOSITION - An ingestible oral health composition has synergistic proportions of active ingredients consisting of: baking soda; guava leaves; turmeric; black pepper; erythritol or xylitol; coconut oil; and vegetable glycerin with a natural flavor extract. The oral health composition may be in the form of a tablet, a powder, a paste, or a suspension. The oral health composition provides superior cleaning and control of oral health problems. The oral health composition can be ingested to provide health benefits to the entire body. | 2019-09-05 |
20190269608 | PET CHEW WITH DENTAL HEALTH FUNCTION - A pet chew with a dental health function includes a carrier and plural dental health members disposed on the surface of interior of the carrier. The dental health members include probiotic, prebiotic and adhesive. The probiotic is a human intestinal probiotic group, and a human beneficial probiotic. Since pets like molar, the chew induces a pet to chew for more than 3 minutes, and the probiotic and prebiotic can clean the pet's teeth during the long chewing time. An adhesive is mixed into the probiotic and prebiotic, so that a large amount of probiotic and prebiotic is adhered into the pet's mouth. The prebiotic promotes the colonization of the probiotic, forms advantageous probiotic groups, and inhibits the breeding of germs in the pet's mouth, and the growth of human harmful germs, so as to achieve the effects of maintaining the pet's oral health and eliminating bad breath. | 2019-09-05 |
20190269609 | A MULTI-COMPONENT INJECTION - The invention relates to the technical field of medicines, and particularly relates to a multi-component injection and preparation processes and applications thereof. In the present invention, the effective ingredients of safflower carthamus. Red Paeony Root, | 2019-09-05 |
20190269610 | SHORT DURATION DEPOT FORMULATIONS - Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, depot gel compositions that can be injected into a desired location and which can provide controlled release of a beneficial agent over a short duration of time. The compositions include a low molecular weight biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent. | 2019-09-05 |
20190269611 | In Situ Gel-Forming Pharmaceutical Compositions and Uses Thereof for Sinus Diseases - The present invention provides pharmaceutical compositions comprising an antiseptic and a steroid, useful for treating a clinical symptom in a patient's airway (e.g., nose, lung, and sinus), wherein a gel containing the antiseptic is formed in situ upon instillation of the compositions onto a body cavity of a subject, as well as methods for using the same. | 2019-09-05 |
20190269612 | PRESERVATIVE FREE PHARMACEUTICAL COMPOSITIONS FOR OPHTHALMIC ADMINISTRATION - The present invention relates to a preservative-free, aqueous solution in the form of eye drops packed in a container that ensures stability of the product, ideal eye drop volume and reduced drop volume variability and provides efficient dispensing. | 2019-09-05 |
20190269613 | METHOD FOR TREATING DRY EYE SYNDROME - A method of preventing or treating an eye condition includes administering a sterile aqueous ophthalmic solution to an eye for the prevention or treatment of dry eye syndrome or dry eye sign and/or dry eye symptom. The sterile aqueous ophthalmic solution includes about 0.05% to about 0.5% (w/w) of N—(N-acetylcysteinyl-)chitosan or a pharmaceutically acceptable salt thereof in a carrier solution, wherein the N—(N-acetylcysteinyl-)chitosan has a content of free thiol groups in an amount of from 80 μmol/g polymer to 280 μmol/g polymer. | 2019-09-05 |
20190269614 | CHEWABLE TABLET CONTAINING VITAMIN C SODIUM AND PREPARATION METHOD THEREOF - The present application provides a chewable tablet containing vitamin C sodium. The chewable tablet includes the following components in parts by weight: 20-100 parts of vitamin C sodium, 100-500 parts of starch, 10-30 parts of sweetener, 5-20 parts of mannitol, 30-100 parts of microcrystalline cellulose, 5-20 parts of povidone K-30, 20-60 parts of sodium carboxymethyl starch, 5-20 parts of sodium dodecyl sulfate, 1-5 parts of magnesium stearate and 0.1-0.5 part of mint essence. The present application is easy to prepare, sweet in taste and stable in quality. | 2019-09-05 |
20190269615 | METHODS AND COMPOSITIONS FOR MODIFYING THE BEHAVIOR OF ANIMALS - A composition comprising Quinoline is described for the modification of undesirable or harmful behaviors or other behaviors or physiology in a variety of vertebrate species, as well as methods of using the compositions in vertebrates. | 2019-09-05 |
20190269616 | STERILE PARENTERAL SUSPENSIONS - The present invention relates to bulk sterilized parenteral suspension formulations comprising water insoluble drugs suitable for parenteral use. Further, a process of preparation of such bulk sterilized suspension compositions employing conventional sterilization process under homogenization is also disclosed. The sterilization under homogenization is carried for prolonged period and the finally aseptically filled into suitable container closure systems. The bulk sterilized suspensions prepared by using the current invention exhibited good physical and chemical stability. | 2019-09-05 |
20190269617 | Methods of Controlling Morphology of Polymeric Nanoparticles - The present disclosure generally relates to methods of making nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. | 2019-09-05 |
20190269618 | A NOVEL METHOD FOR OBTAINING EFFICIENT VIRAL VECTOR-BASED COMPOSITIONS FOR VACCINATION OR GENE THERAPY - The present invention relates to a method for preparing viral vector-based compositions wherein the viral vector-based particles present in the composition have a particle size distribution with a polydispersity index (PDI) of less than 0.5, the method comprising the steps: (a) providing replication-deficient viral vectors; (b) providing a solution comprising at least one sugar and at least three different excipients selected from hydrophilic and amphiphilic excipients, wherein the excipients are characterized by polar, aliphatic, aromatic, negatively charged, and/or positively charged functional groups, and wherein the solution is further characterized by an excipient-sugar ratio of at least 1:2 (w/w); and (c) mixing the replication deficient viral vectors of step (a) with the solution of step (b). The present invention further relates to a viral vector-based composition obtainable by the method of the invention as well as to the viral vector-based composition of the invention for use as a prime-boost vaccine. | 2019-09-05 |
20190269619 | SOLID DISPERSIONS COMPRISING A SGC STIMULATOR - The present invention relates to solid dispersions of amorphous 1,1,1,3,3,3-hexafluoro-2-(((5-fluoro-2-(1-(2-fluorobenzyl)-5-(isoxazol-3-yl)-1H-pyrazol-3-yl)pyrimidin-4-yl)amino)methyl)propan-2-ol (Compound I) or a pharmaceutically acceptable salt thereof. It also relates to pharmaceutical compositions and pharmaceutical oral dosage unit forms comprising them, and their uses thereof. | 2019-09-05 |
20190269620 | PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME - The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone. | 2019-09-05 |
20190269621 | TAMPER-RESISTANT TABLET PROVIDING IMMEDIATE DRUG RELEASE - The invention relates to a tamper-resistant tablet comprising
| 2019-09-05 |
20190269622 | PARTICLE CONTAINING AT LEAST A VOLATILE SUBSTANCE AND PROCESS FOR ITS PREPARATION - The invention is directed to a particle containing at least a volatile substance comprising a core comprising at least one matrix material and the at least one volatile substance and at least one coating layer, whereby a first coating layer is a non-confluent layer comprising at least a carrier material, whereby optionally the non-confluent layer contains at least one hydrophobic substance, and optionally the particle is surrounded by at least one confluent layer and/or further non-confluent layer(s) as well as to a process for producing the same. | 2019-09-05 |
20190269623 | SOFT GEL COMPOSITIONS AND CAPSULES MADE FROM THE SAME - The present disclosure generally relates to film-forming compositions and capsules formed from such compositions, including processes for using such compositions to make capsules. In some embodiments, the film-forming compositions are free of animal products and carrageenan. | 2019-09-05 |
20190269624 | MEDICINAL AGENT-CONTAINING MOLECULAR ASSEMBLY WHICH USES AMPHIPHILIC BLOCK POLYMER - Provided is a molecular assembly (for example, a polymeric micelle nanoparticle) which is capable of efficiently encapsulating a fat-soluble drug. A molecular assembly comprising: an amphiphilic block polymer A1 comprising a hydrophilic block having a sarcosine unit and a hydrophobic block having a lactic acid unit; a hydrophobic polymer A2 having a lactic acid unit; a fatty acid triglyceride; and a fat-soluble drug. Examples of the fat-soluble drug include miriplatin. | 2019-09-05 |
20190269625 | Printed Delivery Device Having Supplements - Printed delivery devices are disclosed herein. In some embodiments, a printed delivery device includes a support substrate. A first printed composition, including a first supplement, is coated onto the support substrate and a second printed composition disposed on the first printed composition. A decorative film is applied to one or more of the first printed composition, second printed composition, or the support substrate. | 2019-09-05 |
20190269626 | Hair Protection Effect of Vanillyl Alkyl Ether and the Application thereof - This invention discloses a hair protection effect of vanillyl alkyl ether and the application thereof. The mentioned application comprises the process of topically applying a composition comprising vanillyl alkyl ether compound to reduce hair loss. | 2019-09-05 |
20190269627 | MEMANTINE COMBINATIONS AND USE - A pharmaceutical combination of memantine and a non-anticholinergic antiemetic agent for the treatment of hypocholinergic disorders in further combination with high doses of donepezil and with solifenacin, and kits comprising said combination. A pharmaceutical combination of memantine and solifenacin for the treatment of hypocholinergic disorders, including Alzheimer type dementia, in further combination with high doses of donepezil, and kits comprising said combination. | 2019-09-05 |
20190269628 | ROOM TEMPERATURE STORAGE STABLE TRIENTINE COMPOSITION - The invention relates to a room temperature storage stable trientine composition comprising of pharmaceutically acceptable solid oral dosage form of trientine; and oxidation resistant container system. The invention also relates to a method of storing trientine solid oral composition at room temperature without degradation. | 2019-09-05 |
20190269629 | COMPOSITIONS AND METHODS FOR INHIBITING GROWTH OF ACSL4-OVEREXPRESSING TUMORS - Compositions and methods for inhibiting tumor growth, particularly breast cancer, in a combined pharmacological treatment. A pharmaceutical combination for inhibiting growth of a tumor overexpressing ACSL4, having a first and a second dosage forms. The first dosage form has an ACSL4 inhibitor and the second dosage form has a chemotherapeutic agent. | 2019-09-05 |
20190269630 | COMPOSITION AND METHOD FOR ENHANCING WOUND HEALING - The invention relates to a composition for enhancing wound healing and/or for reducing pain and inflammation, comprising a first active ingredient and a second active ingredient, wherein the first active ingredient comprises an antiseptic and the second active ingredient comprises an admixture of at least one vitamin, at least one mineral and at least one amino acid, and to use of the composition for enhancing wound healing. | 2019-09-05 |
20190269631 | SIDEROPHORE-POLYMER CONJUGATES FOR INCREASING BACTERIAL SENSITIVITY TO ANTIBIOTICS - The present technology provides siderophore-polymer conjugates that enhance the sensitivity of bacteria to antibiotics, e.g., | 2019-09-05 |
20190269632 | Carmustine Pharmaceutical Composition - The present invention provides pharmaceutical formulations of lyophilized carmustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized carmustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with carmustine, such as neoplastic diseases. | 2019-09-05 |
20190269633 | COMPOSITION FOR PREVENTION OR TREATMENT OF CHRONIC PAIN COMPRISING EVANS BLUE - The present disclosure relates to a pharmaceutical composition or food composition including Evans blue for prevention or treatment of chronic pain diseases. The administration of Evans blue according to the present disclosure can effectively reduce chronic pain, such as neuropathic pain. In particular, Evans blue targets mainly VNUT protein of dorsal root ganglia, which plays an important role in the secretion of ATP from the distal end of the afferent nerve and can relieve the pain using drugs continuously without side effects so that it can be efficiently used as an analgesic for various kinds of pain caused by chronic pain diseases. | 2019-09-05 |
20190269634 | Volatile Organic Compound Formulations Having Antimicrobial Activity - The present invention includes novel chemical formulations having antimicrobial activity and their methods of use thereof. In some embodiments, the formulation further comprises at least one fungus. | 2019-09-05 |
20190269635 | LIPSOMAL ANTICANCER COMPOSITIONS - Provided herein includes methods and compositions for the treatment of cancer. Described herein are liposome encapsulated chemotherapeutic agents, encompassing a weakly basic anticancer compound and an acid or salt thereof, wherein the acid is oxalic acid or tartaric acid and methods for preparing and utilizing the same. | 2019-09-05 |
20190269636 | TREATMENT OF PAIN WITH TOPICAL DICLOFENAC - The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users. | 2019-09-05 |
20190269637 | Alkylamido Compounds and Uses Thereof - Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same. | 2019-09-05 |
20190269638 | COMPOSITION FOR TREATING ADULT T CELL LEUKEMIA/LYMPHOMA AND METHOD FOR PRODUCING SAME - A nutrition formulation, which is substantially free of at least one of valine and methionine and which is capable of parenteral or enteral administration. The nutrition formulation supplies sufficient nutrients to sustain life for at least three weeks by successive administration. A composition containing the nutrition formulation can be used for treating adult cell leukemiallymphoma. | 2019-09-05 |
20190269639 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME - The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders. | 2019-09-05 |
20190269640 | MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS - Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof. | 2019-09-05 |
20190269641 | MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS - Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof. | 2019-09-05 |
20190269642 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES IN A SUBJECT ON CONCOMITANT STATIN THERAPY AND HAVING HSCRP LEVELS OF AT LEAST ABOUT 2 MG/L - In various embodiments, the present disclosure provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof having triglyceride levels of about 200 mg/dL to about 499 mg/dL, and hsCRP levels ≥2.0 mg/L. | 2019-09-05 |
20190269643 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF - The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels. Aqueous solutions including salts of the instant invention are formulated for nasal administration and provide a novel therapeutic platform for the treatment of stable angina, migraine, and cardiac arrhythmia, such as paroxysmal supraventricular tachycardia. | 2019-09-05 |
20190269644 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH CORTICO-HIPPOCAMPAL HYPERACTIVITY - The present invention provides pharmaceutical compositions and methods for preventing, delaying onset of, or treating diseases or disorders associated with cortico-hippocampal hyperactivity such as epilepsy, using an active agent capable of reducing dihydroorotate dehydrogenase (DHODH) enzyme activity in the central nervous system, optionally together with a pyrimidine nucleobase or an intermediate in the de novo synthesis thereof. | 2019-09-05 |
20190269645 | USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS - Methods of administering ferric citrate to reduce and/or control serum phosphorus levels, increase serum bicarbonate levels, improve one or more iron storage parameters (e.g., increase serum ferritin levels, increase transferrin saturation (TSAT), increase hemoglobin concentration) increase iron absorption, maintain iron stores, treat iron deficiency, treat anemia, reduce the need for IV iron and/or reduce the need for erythropoiesis-stimulating agents (ESAs) in chronic kidney disease patients, are disclosed. | 2019-09-05 |
20190269646 | USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF IN COMBINATION WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND BRAIN METASTASES - The use of dianhydrogalactitol provides a novel therapeutic modality for the treatment of non-small-cell lung carcinoma (NSCLC) and ovarian cancer, as well as other types of malignancy, including brain metastases of NSCLC. Dianhydrogalactitol acts as an alkylating agent on DNA that creates N | 2019-09-05 |
20190269647 | METHODS OF TREATMENT USING 4-METHYLUMBELLIFERONE AND DERIVATIVES THEREOF - 4-methylumbelliferone is useful for the treatment of autoimmune diseases, such as primary sclerosing cholangitis (PSC). | 2019-09-05 |
20190269648 | USE OF ARTEMISININ FOR TREATING TUMORS INDUCED BY ONCOGENIC VIRUSES AND FOR TREATING VIRAL INFECTIONS - In certain aspects, the invention relates to methods of treating proliferative cervical disorders (such as cervical cancer and cervical dysplasia) and treating virus infection by administering artemisinin-related compounds. In certain aspects, the invention relates to methods of treating a tumor induced by an oncogenic virus, methods of killing or inhibiting a squamous cell carcinoma, and methods of inhibiting the replication of a virus, by administering artemisinin-related compounds. | 2019-09-05 |
20190269649 | ORAL DISSOLVABLE FILM THAT INCLUDES PLANT EXTRACT - Films (ODFs) that include botanical extract are provided, as well as methods of making and using the same. | 2019-09-05 |
20190269650 | NEW SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS - 3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4. | 2019-09-05 |
20190269651 | SALINOSPORAMIDES AND METHODS OF USE THEREOF - The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithet Salinospora has been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low IC | 2019-09-05 |
20190269653 | Controlled-Release Melatonin Compositions and Related Methods - An oral melatonin pharmaceutical dosage form that contains a sustained release dose of melatonin includes melatonin and an acid dispersed in a hydrogel-forming polymer matrix that combine after ingestion to form an acidic hydrogel containing the melatonin. | 2019-09-05 |
20190269654 | COMBINATION TREATMENT OF CANCER - The present invention relates to treatment of cancer, in particular to methods of sensitising cancer cells to an anti-cancer therapy by administering an effective amount of a modulator of Volume Regulated Anion Channels, i.e. a VRAC modulator. | 2019-09-05 |
20190269655 | METHODS OF TREATING ACUTE KIDNEY INJURY - The present invention also contemplates a method of treating a human patient with acute kidney injury or reducing the likelihood of developing acute kidney injury in a human patient at risk of developing acute kidney injury comprising administering to the patient a poly-ADP ribose polymerase (PARP) inhibitor in a therapeutically effective dose so as to thereby treat the patient. | 2019-09-05 |
20190269656 | Combination Therapies Using Indazolylbenzamide Derivatives for the Treatment of Cancer - The invention relates to combination therapies useful in the treatment and/or prevention of cancer. | 2019-09-05 |
20190269657 | METHODS OF TREATING PEDIATRIC PATIENTS USING DEXMEDETOMIDINE - The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery. | 2019-09-05 |
20190269658 | PHARMACEUTICAL COMPOSITIONS DIRECTLY TARGETING FKBP52 FOR THE TREATMENT OF PROSTATE CANCER AND METHODS OF USING SAME - Embodiments of the current invention include methods and compositions for regulating the activity of hormone receptors. | 2019-09-05 |
20190269659 | (2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYLOXAZOLE- -2-CARBONYL)AMINO]PENTANOIC ACID - In one aspect, the invention relates to a compound of the structure: | 2019-09-05 |
20190269660 | FORMULATION OF A RILUZOLE SOLUTION WITH BETA- CYCLODEXTRINS - The present invention provides methods for parenterally administering riluzole to subjects in need of treatment. | 2019-09-05 |
20190269661 | ENHANCED DELIVERY OF IMMUNOSUPPRESSIVE DRUG COMPOSITIONS FOR PULMONARY DELIVERY - The present invention includes compositions and methods for making and using a rapid dissolving, high potency, substantially amorphous nanostructured aggregate for pulmonary delivery of tacrolimus and a stabilizer matrix comprising, optionally, a polymeric or non-polymeric surfactant, a polymeric or non-polymeric saccharide or both, wherein the aggregate comprises a surface area greater than 5 m | 2019-09-05 |
20190269662 | SOLID COMPOSITIONS OF ACTIVES, PROCESSES FOR PREPARING SAME AND USES OF SUCH SOLID COMPOSITIONS - The present invention provides a solid maraviroc composition, comprising nanoparticles including maraviroc dispersed within a mixture of at least one hydrophilic polymer and at least one surfactant; wherein the hydrophilic polymer is selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC) and polyvinylpyrrolidone (PVP), or a combination thereof; and the surfactant is selected from a polyoxyethylene sorbitan fatty acid ester, sodium deoxycholate, dioctyl sodium sulfosuccinate and polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA) or a combination thereof. | 2019-09-05 |